Hector Aguilar-Carreno & Partners Develop Nasal Spray to Combat Pandemic Viruses

A nasal spray developed by Dr. Hector Aguilar-Carreno and partners has been effective at preventing or minimizing the severity of COVID in mice, and several other deadly viruses and airborne viral diseases in cells.

The team has now received up to $12.76 million dollars over four years from the federal government’s Advanced Research Projects Agency for Health (ARPA-H) for further development and, eventually, human trials.

Read the full story: A broad-spectrum antiviral just got a multimillion-dollar shot in the arm.